MedTrace Logo

Efficacy of Proton Pump Inhibitors in Gastrointestinal Erosions and/or Ulcers

NCT03315676 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2021-09-21

No results posted yet for this study

Summary

The aim of this study is to collect the data of clinical efficacy and safety after the usage of bonoprazon and esomeprazole when the patients take NSAIDs more than 2 weeks and have gastrointestinal symptoms who have had gastrointestinal erosions and/or ulcers in the past.

Conditions

  • Gastrointestinal Erosions and/or Ulcers

Interventions

DRUG

Oral Bonoprazan

To examine the efficacy of oral Bonoprazan in patients with NSAIDs-induced Erosions and/or Ulcers

DRUG

Oral Esomeprazol

To examine the efficacy of oral Esomeprazol in patients with NSAIDs-induced Erosions and/or Ulcers

Sponsors & Collaborators

  • Shinshu University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2022-11-21
Completion
2025-09-04

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03315676 on ClinicalTrials.gov